Prognostic significance of tumour Ki-67 dynamics during neoadjuvant treatment in patients with breast cancer: a population-based cohort studyResearch in context

Summary: Background: Although Ki-67 is a commonly used proliferation marker in breast cancer (BC), its prognostic value after neoadjuvant chemotherapy (NACT) remains unclear. This study aims to investigate the prognostic implications of Ki-67 dynamics during NACT. Methods: Patients with invasive BC...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Maria Angeliki Toli, Xingrong Liu, Davide Massa, Stefania Lando, Caroline Boman, Nikolaos Tsiknakis, Christian Tranchell, Andri Papakonstantinou, Giuseppe Fotia, Claudio Vernieri, Valentina Guarneri, Jonas Bergh, Maria Vittoria Dieci, Louise Eriksson Bergman, Alexios Matikas, Theodoros Foukakis
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2025-11-01
Edice:	The Lancet Regional Health. Europe
Témata:	Breast cancer Neoadjuvant chemotherapy Ki-67 Prognosis Survival Stratification
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2666776225002248
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!